MCP
ABBV icon

Militia Capital Partners’s AbbVie ABBV Stock Holding History

Militia Capital Partners’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$274K Buy
+1,200
New +$273K 0.1% 163
2025
Q2 		– Sell
-602
Closed -$126K – 178
2025
Q1 		$126K Hold
602
– – 0.1% 112
2024
Q4 		$107K Buy
+602
New +$111K 0.1% 126

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Militia Capital Partners's ABBV Position: Q4 2025 in Review

Militia Capital Partners opened a new position in AbbVie (ABBV) in Q4 2025: 1,200 shares worth $274K. The stake represents 0.1% of the portfolio and ranks #163 among its holdings. This is a return to the name: Militia Capital Partners previously reported a position in ABBV as recently as Q1 2025.

Militia Capital Partners first reported a position in ABBV in Q4 2024 and has held it in 3 quarters since. 4,146 funds tracked by Wall St. Rank hold ABBV as of Q4 2025.

  • Militia Capital Partners held 1,200 shares of AbbVie worth $274K as of Q4 2025.
  • AbbVie was a new Militia Capital Partners position in Q4 2025.
  • AbbVie made up 0.1% of Militia Capital Partners's portfolio in Q4 2025, its #163 holding.
  • Militia Capital Partners first reported a position in AbbVie in Q4 2024 and has held it in 3 quarters since.
  • 4,146 funds tracked by Wall St. Rank held AbbVie as of Q4 2025.

Based on Militia Capital Partners's 13F filing for Q4 2025, filed 17 Feb 2026.